title: Controversies in Persistent (Chronic) Lyme Disease.
abstract: The Centers for Disease Control and Prevention estimates that more than 300 000 new cases of Lyme disease occur each year in the United States and that 10% to 20% of these patients will remain symptomatic despite receiving appropriate antibiotic therapy. Many elements of the disease are poorly understood and have generated considerable controversy. This paper discusses the medical controversies related to posttreatment manifestations and their potential impact on infusion nurses.
authors.affiliation: Partnership for Healing and Health, Wyoming, Minnesota. Elizabeth L. Maloney, MD, is the president of Partnership for Health and Health, Ltd. She develops educational materials on tick-borne illnesses, including accredited continuing medical education courses for physicians and nurses, and has published papers and letters on Lyme disease in peer-reviewed journals.
authors.forename: Elizabeth L
authors.initials: EL
authors.lastname: Maloney
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D025065:Borrelia burgdorferi; D002908:Chronic Disease; D004334:Drug Administration Schedule; D006801:Humans; D008193:Lyme Disease / Q000175:diagnosis / Q000188:drug therapy*; D024802:Nurse's Role; D014481:United States
chemical_list: D000900:Anti-Bacterial Agents